LEN vs USBC
LEN (LEN) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
LEN currently screens at market cap $0. USBC currently screens at market cap $0.
Not investment advice. Open the LEN and USBC stock pages for the full models.
Not investment advice.